AAAAAA

   
Results: 1-11 |
Results: 11
P53 GENE ALTERATIONS ARE ASSOCIATED WITH A DECREASED RESPONSIVENESS TO NEOADJUVANT CHEMOTHERAPY IN HUMAN BREAST-CANCER
Authors: LIZARDNACOL S COUDERT B RIEDINGER JM FARGEOT P GUERRIN J
Citation: S. Lizardnacol et al., P53 GENE ALTERATIONS ARE ASSOCIATED WITH A DECREASED RESPONSIVENESS TO NEOADJUVANT CHEMOTHERAPY IN HUMAN BREAST-CANCER, International journal of oncology, 10(6), 1997, pp. 1203-1207
HYPOGLYCEMIA-INDUCED BY INTERFERON-ALPHA THERAPY
Authors: ISAMBERT N COUDERT B JOLIMOY G SGRO C GUERRIN J
Citation: N. Isambert et al., HYPOGLYCEMIA-INDUCED BY INTERFERON-ALPHA THERAPY, La Presse medicale, 26(18), 1997, pp. 855-855
LOSS OF HETEROZYGOSITY AT THE TP53 GENE - INDEPENDENT OCCURRENCE FROMGENETIC INSTABILITY EVENTS IN NODE-NEGATIVE BREAST-CANCER
Authors: LIZARDNACOL S RIEDINGER JM LIZARD G GLASSER AL COUDRAY N CHAPLAIN G GUERRIN J
Citation: S. Lizardnacol et al., LOSS OF HETEROZYGOSITY AT THE TP53 GENE - INDEPENDENT OCCURRENCE FROMGENETIC INSTABILITY EVENTS IN NODE-NEGATIVE BREAST-CANCER, International journal of cancer, 72(4), 1997, pp. 599-603
CLINICAL INTEREST OF ESTIMATION OF THE GROWTH-KINETICS OF OVARIAN PRIMARY RECURRENCES BY CA125 DOUBLING TIME
Authors: RIEDINGER JM COUDERT B BARILLOT I BUFFENOIR G MAYER F FARGEOT P CUISENIER J GUERRIN J
Citation: Jm. Riedinger et al., CLINICAL INTEREST OF ESTIMATION OF THE GROWTH-KINETICS OF OVARIAN PRIMARY RECURRENCES BY CA125 DOUBLING TIME, Bulletin du cancer, 84(9), 1997, pp. 855-860
ADJUVANT TREATMENT OF NODE-POSITIVE BREAST-CANCER WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, FLUOROURACIL AND VINCRISTINE VERSUS CYCLOPHOSPHAMIDE,METHOTREXATE, AND FLUOROURACIL - FINAL REPORT AFTER A 16-YEAR MEDIAN FOLLOW-UP DURATION
Authors: MISSET JL DIPALMA M DELGADO M PLAGNE R CHOLLET P FUMOLEAU P LEMEVEL B BELPOMME D GUERRIN J FARGEOT P METZ R ITHZAKI M HILL C MATHE G
Citation: Jl. Misset et al., ADJUVANT TREATMENT OF NODE-POSITIVE BREAST-CANCER WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, FLUOROURACIL AND VINCRISTINE VERSUS CYCLOPHOSPHAMIDE,METHOTREXATE, AND FLUOROURACIL - FINAL REPORT AFTER A 16-YEAR MEDIAN FOLLOW-UP DURATION, Journal of clinical oncology, 14(4), 1996, pp. 1136-1145
PROGNOSTIC-SIGNIFICANCE OF THE CA-125 INI TIAL HALF-LIFE MEASURED DURING FIRST-LINE CHEMOTHERAPY IN 62 PATIENTS WITH EPITHELIAL OVARIAN-CANCER STAGE-III OR STAGE-IV
Authors: RIEDINGER JM BARILLOT I COUDERT B FARGEOT P BERRIOLORIEDINGER A GUERRIN J
Citation: Jm. Riedinger et al., PROGNOSTIC-SIGNIFICANCE OF THE CA-125 INI TIAL HALF-LIFE MEASURED DURING FIRST-LINE CHEMOTHERAPY IN 62 PATIENTS WITH EPITHELIAL OVARIAN-CANCER STAGE-III OR STAGE-IV, Bulletin du cancer, 83(8), 1996, pp. 654-663
THERAPEUTIC MONITORING OF 120 HOURS CONTI NUOUS 5-FLUOROURACIL ASSOCIATED WITH CISPLATIN
Authors: COUDERT B DEGISLAIN C BELTRAMO JL GUIGUES B MAYER F BRUCHON Y RIEDINGER JM FARGEOT P DUMAS M GUERRIN J
Citation: B. Coudert et al., THERAPEUTIC MONITORING OF 120 HOURS CONTI NUOUS 5-FLUOROURACIL ASSOCIATED WITH CISPLATIN, Bulletin du cancer, 83(10), 1996, pp. 847-852
FEASIBILITY OF 5-FU THERAPEUTIC MONITORING
Authors: COUDERT B DEGISLAIN C",BELTRAMO,"RIEDINGER JM MAYER F BRUCHON FY DUMAS M FARGEOT P GUERRIN J
Citation: B. Coudert et al., FEASIBILITY OF 5-FU THERAPEUTIC MONITORING, European journal of cancer, 31A, 1995, pp. 966-966
BENIGN BREAST DISEASE - ABSENCE OF GENETIC ALTERATIONS AT SEVERAL LOCI IMPLICATED IN BREAST-CANCER MALIGNANCY
Authors: LIZARDNACOL S LIDEREAU R COLLIN F ARNAL M HAHNEL L ROIGNOT P CUISENIER J GUERRIN J
Citation: S. Lizardnacol et al., BENIGN BREAST DISEASE - ABSENCE OF GENETIC ALTERATIONS AT SEVERAL LOCI IMPLICATED IN BREAST-CANCER MALIGNANCY, Cancer research, 55(19), 1995, pp. 4416-4419
AMPLIFICATION OF C-MYC AND C-ERB-BETA-2 ( HER-2 NEU) IN BREAST-CANCERWITHOUT LYMPH-NODE INVOLVEMENT - CORRELATION WITH OTHER PROGNOSTIC PARAMETERS/
Authors: LIZARDNACOL S ARNOULD L RIEDINGER JM ARNAL M COLLIN F GUERRIN J
Citation: S. Lizardnacol et al., AMPLIFICATION OF C-MYC AND C-ERB-BETA-2 ( HER-2 NEU) IN BREAST-CANCERWITHOUT LYMPH-NODE INVOLVEMENT - CORRELATION WITH OTHER PROGNOSTIC PARAMETERS/, Bulletin du cancer, 81(9), 1994, pp. 780-784
ALL MIXED UP -REVIEW BY GAZZANIGA,M.S.( COMMENT ON A RECENT BOOK)
Authors: GUERRIN J
Citation: J. Guerrin, ALL MIXED UP -REVIEW BY GAZZANIGA,M.S.( COMMENT ON A RECENT BOOK), The New York times book review, 1993, pp. 39-39
Risultati: 1-11 |